Lisa Blunt Rochester

Overview

Lisa Blunt Rochester is a Democratic U.S. Senator from Delaware with 632 recorded votes. Her voting record reflects consistent alignment with Democratic Party positions across a wide range of policy areas. She has shown the strongest bipartisan tendencies on trade-related legislation, where she voted in favor 83% of the time, and on healthcare measures, where she supported roughly 57% of the bills that came to a vote. On defense and military policy, her votes are evenly split, reflecting a case-by-case approach. She has supported measures requiring congressional authorization before military action, as seen in her votes on resolutions regarding U.S. armed forces involvement with Iran. She has also opposed certain defense authorization bills, suggesting she evaluates military spending proposals individually rather than backing them uniformly. Senator Blunt Rochester has voted against the majority of executive branch nominations and appointments that reached the Senate floor, which is consistent with the pattern of the minority party opposing majority-party nominees. Her low approval rates on foreign policy votes (1.9% Yea) and environment and energy votes (19% Yea) largely reflect opposition to bills sponsored by the opposing party rather than blanket opposition to those policy areas. Her record on social safety net issues — including Social Security, labor, and housing — shows she has consistently opposed measures in those categories that came to a vote, which in the current Senate likely means she opposed proposed changes or cuts to those programs. On taxation, she supported about 38% of measures, suggesting selective engagement with tax-related legislation.

Key Positions

• •Voted to require congressional authorization before U.S. military involvement with Iran, supporting the principle that Congress should approve military action before it occurs.
• •Supported a healthcare point of order aimed at addressing insurance company practices of delaying or denying patient access to care, reflecting concern about insurance industry oversight.
• •Opposed the nomination of Erica Schwartz to lead the Centers for Disease Control and Prevention, along with multiple other executive branch nominations.
• •Showed the highest bipartisan agreement on trade legislation, voting in favor of 5 out of 6 trade-related measures.
• •Voted against the fiscal year 2027 defense authorization bill, which sets military spending levels and policy for the Department of Defense.
• •Cast her sole reproductive rights vote in favor, though with only one recorded vote in this category, a broader pattern cannot be established.
• •Voted in favor of a resolution related to PFAS chemical reporting requirements under the Toxic Substances Control Act, supporting environmental accountability measures.
• •Consistently voted against budget proposals brought to the floor, opposing roughly 77% of budget-related measures.